Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas.
about
rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq datajSplice: a high-performance method for accurate prediction of alternative splicing events and its application to large-scale renal cancer transcriptome data.Transcriptome analysis of human tissues and cell lines reveals one dominant transcript per geneCancer genomic research at the crossroads: realizing the changing genetic landscape as intratumoral spatial and temporal heterogeneity becomes a confounding factor.Genome-wide analysis of differentially expressed genes and splicing isoforms in clear cell renal cell carcinoma.Transcriptome-wide landscape of pre-mRNA alternative splicing associated with metastatic colonizationCharacterization of long non-coding RNA transcriptome in clear-cell renal cell carcinoma by next-generation deep sequencing.ISOexpresso: a web-based platform for isoform-level expression analysis in human cancerRenal Mechanisms of Association between Fibroblast Growth Factor 1 and Blood Pressure.Expression of the FGFR2 mesenchymal splicing variant in epithelial cells drives epithelial-mesenchymal transition.SURVIV for survival analysis of mRNA isoform variation.Epithelial splicing regulatory protein 1 and 2 paralogues correlate with splice signatures and favorable outcome in human colorectal cancer.Integrative analysis of protein-coding and non-coding RNAs identifies clinically relevant subtypes of clear cell renal cell carcinoma.Role of CD56 in Normal Kidney Development and Wilms Tumorigenesis.EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression.Human PDE4D isoform composition is deregulated in primary prostate cancer and indicative for disease progression and development of distant metastases.The Arkadia-ESRP2 axis suppresses tumor progression: analyses in clear-cell renal cell carcinomaImmunoscoring by correlating MHC class II and TCR expression: high level immune functions represented by the KIRP dataset of TCGA.Somatic Mutations and Splicing Variants of Focal Adhesion Kinase in Non-Small Cell Lung Cancer.Expression of the FGFR2c mesenchymal splicing variant in human keratinocytes inhibits differentiation and promotes invasion.Variation in genomic landscape of clear cell renal cell carcinoma across Europe.Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.Global isoform-specific transcript alterations and deregulated networks in clear cell renal cell carcinoma.Role of FGFR2b expression and signaling in keratinocyte differentiation: sequential involvement of PKCδ and PKCα.The Cancer Spliceome: Reprograming of Alternative Splicing in Cancer
P2860
Q30875027-44FAF371-69D8-41FC-902C-FC0210F632D1Q31092204-A4198682-369F-426C-99CE-89E13A1E5249Q33741801-03077F88-BAD3-40A0-8137-B0E315661569Q34537690-9572A7B4-E9EA-45BC-8920-951974C19E6EQ35032590-418F9BAF-4DD3-4594-8D90-32E7F516CD5DQ35108922-63D816B8-20B2-4B68-B435-D0BFF2ADF077Q35892663-C64C56F6-2540-43F7-BE24-6BC1130412CFQ36103082-2BEC9440-9D4D-4622-8046-589BB2EE3C2DQ36314969-1889ED83-1697-4EB4-8F4A-AA7AF088400DQ36905686-945E6393-4962-4BF2-8471-42009014E611Q37000093-D784CBB7-0C95-403A-BB05-31105DE532E0Q37687476-94E938F0-525A-4B88-8DF1-AE77DB430D97Q37696197-CE4158D1-EEB7-4E59-9AB7-9355ABAD3D93Q39034075-9CA0E8BB-163D-4E3E-9F28-5AD9E4DF98E7Q39109931-49F75812-3444-4F4D-A91A-AA6D9F993FD1Q39341456-96815B54-1015-4DE0-95A5-C1352EEA7D86Q40368929-0700DDF6-6060-415D-B512-E8B60362EFA9Q40622089-77B771EC-95AE-44D9-A7B9-34F873118B80Q42778341-FBF3EBCD-BEE3-4CF1-A3B0-BA85C1F73650Q48130149-966492B3-C410-41E4-ADFA-8C01A5797401Q51019551-4F3F7BFA-B26C-44DE-8CBB-B759867E2A2CQ52564290-7EC0EFB2-91F8-43BB-B230-230B918D57C8Q55172634-04B40844-910B-4317-BEF0-A79FB95DDABDQ55262952-ADC65EC2-0FC8-418E-9866-D8DE04A5CD1EQ58758774-CDC14EA4-3975-40FB-ABE8-9FF9399DF4A9
P2860
Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Tumor-specific isoform switch ...... ar cell renal cell carcinomas.
@en
Tumor-specific isoform switch ...... ar cell renal cell carcinomas.
@nl
type
label
Tumor-specific isoform switch ...... ar cell renal cell carcinomas.
@en
Tumor-specific isoform switch ...... ar cell renal cell carcinomas.
@nl
prefLabel
Tumor-specific isoform switch ...... ar cell renal cell carcinomas.
@en
Tumor-specific isoform switch ...... ar cell renal cell carcinomas.
@nl
P2093
P2860
P1476
Tumor-specific isoform switch ...... ar cell renal cell carcinomas.
@en
P2093
Eric Jonasch
Ian D Davis
John N Weinstein
Kenna Shaw for TCGA research network
Otavia L Caballero
Pheroze Tamboli
Robert L Strausberg
W K Alfred Yung
P2860
P304
P356
10.1158/1078-0432.CCR-12-3708
P407
P577
2013-02-26T00:00:00Z